DBVT News and Press, DBV Technologies S.A. From 01/14/21

Montrouge, France, January 14, 2020 DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical compa...

Addex Therapeutics (ADXN) -22% after pricing share offering.Urban One (UONEK) -18%.Urban One (UONE) -17%.Digital Ally (DGLY) -15% after suspends stock offering.Bed Bath & Beyond (BBBY) -14% on Q3 earnings release.SuperCom (SPCB) -12%.DBV Technologies (DBVT)&#...

DBV Technologies (DBVT) has determined that it now qualifies as a U.S. domestic issuer rather than a foreign private issuer in the U.S. As of January 1, the company is subject to SEC and other rules and regulations applicable to U.S. domestic issuers, in addition to French and EU regulations....

Montrouge, France, January 7, 2021 DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process DBV Technologies S.A. (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutic...

TAT Technologies (TATT) +37% after signing strategic agreement with Honeywell.Change Healthcare Inc. (CHNG) +35% as UnitedHealth to acquire the company for $25.75 in cash.DBV Technologies S.A. (DBVT) +19%.Aurora Cannabis (ACB) +17% on possible Georgia 'blue sweep'.HEXO (HEXO) +17%&#...

Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Co...

uniQure (QURE) -18% after the FDA clinical hold on its hemophilia B gene therapy program, including the pivotal, Phase 3 HOPE-B study.MingZhu Logistics Holdings Limited (YGMZ) -11%.CYREN (CYRN) -13%.Transocean (RIG) -11%.The9 (NCTY) -11%.DBV Technologies (DBVT) -11%.FibroG...

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2020 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN Code...

Nabriva Therapeutics NBRV -30% after priced $15M public offering.Aytu BioScience (AYTU) -25% on raising 'bought deal' offering to $25M.Immutep (IMMP) -24%.Professional Diversity Network (IPDN) -24%.SELLAS Life Sciences Group SLS -21% after announcing positiv...

SCWorx (WORX) +100%.Professional Diversity Network (IPDN) +25%.Apex Technology Acquisition (APXT) +20%.Genfit SA (GNFT) +18%.Xinyuan Real Estate (XIN) +17% on Q3 results.Rhythm Pharmaceuticals (RYTM) +16% as FDA OKs it's Imcivree for weight management in obese patients.Shi...